# ceftriaxone

NDC: 25021-107
Generic name: ceftriaxone
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20091105

FDA application: ANDA065329

## Active ingredients

- CEFTRIAXONE SODIUM: 2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-107"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-107
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cf93bc5-9e4c-4734-bc02-c7d0ac071022
